CALHM1 and Alzheimer disease: The CALHM1 P86L polymorphism was found in another study associated with elevated cerebrospinal fluid (CSF) Aβ in normal individuals at risk for AD, which indeed support that CALHM1 controls Aβ metabolism in vitro in cell lines [60] and in vivo in human CSF [62].